SUNNYVALE, Calif.--(BUSINESS WIRE)--Silk Road Medical, Inc., a company dedicated to preventing the devastating burden of stroke through surgical innovation, today announced that medical device industry veteran Donald J. Zurbay has joined its board of directors.
Zurbay brings 28 years of executive leadership and financial experience primarily from the healthcare sector. He previously served as the vice president and chief financial officer of St. Jude Medical, Inc., a Fortune 500 medical device company. During his tenure at St. Jude Medical, Zurbay helped lead the company through significant growth and expansion to a revenue of more than $6 billion, including 19 acquisitions, and Abbott’s acquisition of St. Jude Medical for $25 billion. Prior to St. Jude Medical, Zurbay spent 10 years in public accounting at Deloitte and PricewaterhouseCoopers. Zurbay holds a Bachelor of Science in business from the University of Minnesota and is a licensed certified public accountant.
Read More: https://www.businesswire.com/news/home/20180326005132/en/Silk-Road-Medical-Names-Donald-J.-Zurbay
OncoMed Announces Appointment of John Lewicki, PhD, as President, Chief Executive Officer and a member of the Board of Directors
REDWOOD CITY, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced the appointment of Dr. John Lewicki as President and Chief Executive Officer of OncoMed, effective immediately. Dr. Lewicki was also appointed to the company's Board of Directors.
Via: Trinity Ventures
People who are diagnosed with prediabetes can delay or prevent the disease if they change their lifestyle and lose a significant amount of weight. But here's the challenge: How can people be motivated to eat healthier and move more? Increasingly, the answer might include digital medicine.
Intimidating medical devices can cause anxiety for patients — in the same way that people can experience “white coat hypertension” when seeing a doctor.
HOLLYWOOD, Fla. — Several new technologies are available or on the horizon to improve the outcomes of carotid artery stenting, according to a speaker at the International Symposium on Endovascular Therapy (ISET).
Via: Wall Street Journal
The ‘thrombectomy’ is transforming stroke care, pre-empting brain damage in many patients, but the medical establishment is far from making it standard practice
Loyola First Academic Medical Center in Illinois to Offer TCAR Procedure
Researchers from the University of Nebraska Medical Center and Wake Forest University are collaborating with San Francisco-based Omada Health to explore the effectiveness of a virtual diabetes prevention program.